Noubar Afeyan
$1.27B
as of 10/04/24
About Noubar Afeyan
Noubar Afeyan is the founder and CEO of Cambridge, Mass. life sciences innovation firm Flagship Pioneering.
He's also the chairman and cofounder of biotech firm Moderna, known for its Covid-19 vaccine which was authorized by the U.S. FDA in December 2020.
Afeyan has helped start more than 70 public and private healthcare and life sciences companies over the course of his career.
Born in Beirut, Lebanon, in 1962 to Armenian parents, he and his family fled the Lebanese Civil War to move to Montreal in 1975.
Beyond his stake in Moderna, he also owns shares in more than a dozen publicly traded biotech companies in the U.S.
Personal stats
Citizenship
United States of AmericaSource of wealth
BiotechResidence
Lexington, MassachusettsMarital status
MarriedBirth date
07/25/62 (age 62)Education
Ph.D, Massachusetts Institute of Technology; Bachelor of Science, McGill UniversitySelf-made
self-madeNoubar Afeyan’s fortune is worth
21K
troy ounces of gold
19K
median U.S. household
13K
median U.S. income
0.025%
U.S. credit card volume
0.005%
GDP of the United States
0.004%
United States debt
Net worth history
Annual ranking
Related people
Did you know?
In 2014 he helped launch UWC Dilijan, an international boarding school in the town of Dilijan in the mountains of northern Armenia.
Net worth over time
Real-time ranking
Financial assets
NASDAQ | DNLI-US
Denali TherapeuticsUS OTC | EVLO-US
Evelo BiosciencesNASDAQ | FHTX-US
Foghorn TherapeuticsNASDAQ | MRNA-US
Moderna, Inc.NASDAQ | OMGA-US
Omega TherapeuticsUS OTC | RUBY-US
Rubius TherapeuticsNASDAQ | SANA-US
Sana BiotechnologyNASDAQ | MCRB-US
Seres Therapeutics Inc (MCRB)NASDAQ | SGTX-US
Sigilon TherapeuticsNASDAQ | SYRS-US
Syros PharmaceuticalsImages © Forbes.com. All rights reserved.